Cosmo Pharmaceuticals Appoints Chief Strategy Officer
Dublin, Ireland--(Newsfile Corp. - December 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce...
Pharmaceutical
Medical Gas Blenders Market to Grow by USD 582 Million (2024-2028), Driven by Aging Population and Chronic Diseases, with AI Impacting Market Trends – Technavio
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global medical gas blenders...
Nanomerics Reports First Volunteers Dosed in the OC134 SUNLIGHT Trial
LONDON, UK / ACCESSWIRE / December 11, 2024 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that dosing...
Doceree launches comprehensive healthcare marketing trends report highlighting industry innovations and future opportunities
'Doceree 360 (2024 Edition)' attempts to equip pharma marketers with top and latest trends and industry best practices to craft...
CRO Services Market Surges to USD 188.54 Billion by 2030, Propelled by 12.6% CAGR – Verified Market Reports®
LEWES, Del., Dec. 11, 2024 /PRNewswire/ --The CRO Services Market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource...
MM+M Announces Petauri’s Nicole Lodowski as 40 Under 40 Honoree for 2025
Rapidly growing pharmaceutical services platform leadership recognized for making significant contributions to healthcare marketing and communications. NASHVILLE, Tenn., Dec. 11, 2024...
DeepIntent Launches Pioneering Program to Elevate Third-Party Data Accountability
New Initiative Sets Standards in Data Vendor Compliance, Strengthening Client Confidence in Third-Party Data Sources NEW YORK, Dec. 11, 2024...
Signant Health Names Krishna Maridi, a Finance Leader with Over 25 Years of Experience, as Chief Financial Officer
PHILADELPHIA, Dec. 11, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the...
Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced...
Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 – January 30, 2025
STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage...
Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024
Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation RALEIGH, NC /...
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for...
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
KNOXVILLE, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today the...
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is...
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
Ness-Ziona, Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Angitia Biopharmaceuticals Announces $120 Million Series C Financing
- Financing led by Bain Capital Life Sciences with significant participation from existing and new investors - Proceeds will support...
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage...
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
Citizen Petition seeks correction of expiration date for New Chemical Entity (NCE) exclusivity on VOQUEZNA (vonoprazan) tablets Orange Book listingsPhathom...
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Presentations complement topline data with new data from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive...
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, launching...